We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

99 hedge funds and large institutions have $467M invested in Cullinan Oncology in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25,100% more call options, than puts

Call options by funds: $504K | Put options by funds: $2K

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

36% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 28

11% more funds holding

Funds holding: 89 → 99 (+10)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

1% less capital invested

Capital invested by funds: $473M → $467M (-$6.62M)

2.74% less ownership

Funds ownership: 83.91% → 81.18% (-2.7%)

Holders
99
Holders Change
+10
Holders Change %
+11.24%
% of All Funds
1.71%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
18
Increased
38
Reduced
28
Closed
8
Calls
$504K
Puts
$2K
Net Calls
+$502K
Net Calls Change
+$152K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$8.15M
2
RCMNY
Rubric Capital Management (New York)
New York
+$3.54M
3
CA
CHI Advisors
New York
+$2.63M
4
Goldman Sachs
Goldman Sachs
New York
+$2.18M
5
BlackRock
BlackRock
New York
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$14.9M
2
WP
Woodline Partners
California
-$10.5M
3
Millennium Management
Millennium Management
New York
-$2.32M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.8M
5
CSS
Cubist Systematic Strategies
Connecticut
-$1.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSA
76
Leonteq Securities AG
Switzerland
$64.1K – – –
AB
77
Amalgamated Bank
New York
$50K +$1.1K +82 +2%
Zurich Cantonal Bank
78
Zurich Cantonal Bank
Switzerland
$48K +$50.1K +3,718 New
GCM
79
Gladius Capital Management
Illinois
$36K +$37.1K +2,754 New
Ensign Peak Advisors
80
Ensign Peak Advisors
Utah
$31K +$4.45K +330 +16%
AIP
81
Ameritas Investment Partners
Nebraska
$25K – – –
MLICM
82
Metropolitan Life Insurance Company (MetLife)
New York
$23.5K – – –
TRCT
83
Tower Research Capital (TRC)
New York
$22K +$2.99K +222 +15%
Citigroup
84
Citigroup
New York
$17K -$24.1K -1,790 -57%
QT
85
Quantbot Technologies
New York
$15K +$16.2K +1,200 New
Macquarie Group
86
Macquarie Group
Australia
$14K -$14.8K -1,101 Closed
FF
87
FourThought Financial
Florida
$10K – – –
US Bancorp
88
US Bancorp
Minnesota
$9K +$2.51K +186 +38%
O
89
OrbiMed
New York
$8.17K -$451K -33,500 -5%
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
$5K -$2.67K -198 -34%
CUAMC
91
China Universal Asset Management Company
China
$5K +$5.75K +427 New
Daiwa Securities Group
92
Daiwa Securities Group
Japan
$2K – – –
LC
93
Lindbrook Capital
California
$2K – – –
Wells Fargo
94
Wells Fargo
California
$1K -$3.69K -274 -79%
WTA
95
Washington Trust Advisors
Massachusetts
$1K – – –
Carson Wealth (CWM LLC)
96
Carson Wealth (CWM LLC)
Nebraska
$1K +$323 +24 +120%
S
97
SignatureFD
Georgia
$1K +$323 +24 +60%
WP
98
Woodline Partners
California
– -$10.5M -818,572 Closed
SCM
99
Soleus Capital Management
Connecticut
– -$1.22M -95,485 Closed
TSS
100
Two Sigma Securities
New York
– -$316K -24,640 Closed
1 2 3
4
5

CGEM Hedge Fund Activity: Q3 2022 in Review

99 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q3 2022, worth a combined $467M — down 1.4% from $473M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CGEM positions and 8 closed out — a net gain of 10 holders — while 38 added to existing stakes and 28 trimmed.

The largest buyer was Kennedy Capital Management, adding an estimated $8.15M. The largest seller was Baupost Group, cutting an estimated $14.9M.

  • 99 institutional investors held Cullinan Oncology (CGEM) as of Q3 2022, up from 89 in Q2 2022.
  • Funds reported $467M of Cullinan Oncology stock for Q3 2022, down 1.4% quarter-over-quarter.
  • 18 funds opened new Cullinan Oncology positions in Q3 2022 and 8 closed out, a net change of +10 holders.
  • The largest Cullinan Oncology buyer in Q3 2022 was Kennedy Capital Management, an estimated $8.15M added.
  • The largest Cullinan Oncology seller in Q3 2022 was Baupost Group, an estimated $14.9M sold.

Based on aggregated 13F filings for Q3 2022.